HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$8.37
Day range
$8.21 - $8.46
Year range
$3.51 - $14.44
Market cap
710.29M USD
Avg Volume
892.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.42M | 2.18% |
Net income | -11.20M | -6.16% |
Net profit margin | — | — |
Earnings per share | -0.27 | -107.69% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 115.77M | -16.94% |
Total assets | 117.14M | -18.94% |
Total liabilities | 17.38M | 81.85% |
Total equity | 99.76M | — |
Shares outstanding | 85.37M | — |
Price to book | 7.15 | — |
Return on assets | -25.74% | — |
Return on capital | -29.47% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.20M | -6.16% |
Cash from operations | -5.86M | 49.76% |
Cash from investing | — | — |
Cash from financing | 852.00K | -88.29% |
Net change in cash | -5.00M | -14.27% |
Free cash flow | -158.62K | 98.18% |
About
Founded
2004
Headquarters
Website
Employees
42
